Egyptian Liver Journal

Table 6 HCVcAg at baseline, the 12th week, and the 24th week regarding treatment response

From: Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Response of cases (No. = 280)	HCVcAg (Peiu/ml)
	Baseline	At the 12th week		At the 24th week
	Baseline	Detectable	Undetectable	Detectable	Undetectable
Responder/SVR (No. = 260)	2.7 ± 2.1	0 0.0%	260 100%	0 0.0%	260 100%
Non-responder (No. = 10)	1.7	10 100%	0 0.0%	10 100%	0 0.0%
Relapse (No. = 10)	3.5	0 0.0%	10 100%	10 100%	0 0.0%

Back to article page